About
Florian Denis is a scientifically conversant investor—serving on HEPHAISTOS‑Pharma’s board, offering mechanism-level immunology and clinical strategy guidance, and applying a repeatable early-stage-to-acquisition playbook proven by Gleamer and Mablink exits.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechCleantechCybersecurityDeep TechHardwareHealthtechMedical DevicesSaaS
Experience
- ElaiaPartnercurrent2025 — presentParis, Île-de-France, France
- ElaiaInvestment Director2021 — 2025Paris, Île-de-France, France
- ElaiaInvestment Manager2019 — 2021Greater Paris Metropolitan Region
- BIOPHTABoard Membercurrent2024 — present
- HEPHAISTOS-PharmaBoard Membercurrent2024 — present
- GLEAMERBoard Membercurrent2021 — presentParis, Île-de-France, France
- Mablink BioscienceBoard Member2021 — 2023Lyon, Auvergne-Rhône-Alpes, France
- Société de Bourse Gilbert DupontEquity Research Analyst2019Greater Paris Metropolitan Region
- VitaDXSupervisory Board Member2017 — 2019Paris, Île-de-France, France
- TheranexusBoard Member2017 — 2019
- AurigaLife Sciences Associate2015 — 2019Paris, Île-de-France, France
Skills & more
Biotechnology16Lifesciences9Competitive Intelligence6CK theory3Innovation Management5Business Development8Life Sciences5
Languages English
From Florian's professional profile.
Colleagues at Elaia
Alexis Frentz
Investment Director at Elaia
Anne Bouverot
Independent Board Member at Elaia
Anne-Sophie Carrese
Managing Partner at Elaia
Anya Brochier
Marketing & Communications Senior Associate at Elaia
Arthur Liabastre
Senior Finance Officer at Elaia
Arturo Ancira García
Associate at Elaia
Camille Hamon
Finance Team Manager at Elaia
Celine Passedouet
Investment Director at Elaia
Network4
Alexis Frentz
Investment Director at Elaia
Anne-Sophie Carrese
Managing Partner at Elaia
Armelle de Tinguy
Partner at 115K
Celine Passedouet
Investment Director at Elaia
Investors connected to Florian in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Florian Denis?
- Florian Denis is a scientifically conversant investor—serving on HEPHAISTOS‑Pharma’s board, offering mechanism-level immunology and clinical strategy guidance, and applying a repeatable early-stage-to-acquisition playbook proven by Gleamer and Mablink exits.
- Where does Florian Denis work?
- Florian Denis is Investor at Elaia.
- What does Florian Denis invest in?
- Florian Denis invests in AI & Machine Learning, Biotech, Cleantech, Cybersecurity, Deep Tech, Hardware, Healthtech, Medical Devices, SaaS.
- What check size does Florian Denis write?
- Florian Denis typically writes checks of $100K – $5M.
- Where did Florian Denis go to school?
- Florian Denis studied at Université Paris Dauphine - PSL (Master of Science (M.Sc.), Management de la Technologie et de l'Innovation (MTI)); SupBiotech, école de biotechnologies (Master's degree, Biotechnology); University of Essex.
Same school
Also attended Université Paris Dauphine - PSL255
Aryo TehranianManaging Director at Mayfair Equity PartnersPatrick MalkaGeneral Partner at Newfund CapitalHenri DeshaysGeneral Partner at Newfund CapitalSabrine ChahrourSenior Associate at Partech VenturesPhilippe CollombelFounding & General Partner at Partech VenturesArnaud De KeulenaerSenior Legal Counsel at Partech Ventures
+ 249 more
Also attended SupBiotech, école de biotechnologies1
Also attended University of Essex30
Marie MontlaurLegal Counsel at Partech VenturesMaryam Abu RaghebLegal & Compliance Director at Silicon BadiaTomas AndriuškeviciusPartner at Practica CapitalHans Ivar RobinsonCEO at Birk VentureRobert HerscoviciInvestment Director at GapMinderHarrison Lars-HansenAnalyst at Conexus Venture Capital
+ 24 more
Shared employers
Also worked at Elaia43
Sofia DahouneInvestor at DaphniLoubaba El AyoubiInvestor at NorthzonePhilippe GirePartner at ElaiaXavier LazarusManaging Partner at ElaiaSamantha JérusalmyPartner at ElaiaPauline RouxManaging Partner at Elaia
+ 37 more
